These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34176779)

  • 1. Acute Myeloid Leukemia: Historical Perspective and Progress in Research and Therapy Over 5 Decades.
    Kantarjian HM; Short NJ; Fathi AT; Marcucci G; Ravandi F; Tallman M; Wang ES; Wei AH
    Clin Lymphoma Myeloma Leuk; 2021 Sep; 21(9):580-597. PubMed ID: 34176779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute myeloid leukemia: Treatment and research outlook for 2021 and the MD Anderson approach.
    Kantarjian HM; Kadia TM; DiNardo CD; Welch MA; Ravandi F
    Cancer; 2021 Apr; 127(8):1186-1207. PubMed ID: 33734442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporating newer agents in the treatment of acute myeloid leukemia.
    Raj RV; Abedin SM; Atallah E
    Leuk Res; 2018 Nov; 74():113-120. PubMed ID: 30401522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating acute myeloid leukemia in the modern era: A primer.
    Blum WG; Mims AS
    Cancer; 2020 Nov; 126(21):4668-4677. PubMed ID: 32767757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Utility of Next-Generation Sequencing in Acute Myeloid Leukemia.
    Yang F; Anekpuritanang T; Press RD
    Mol Diagn Ther; 2020 Feb; 24(1):1-13. PubMed ID: 31848884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute myeloid leukemia in older adults.
    Yanada M; Naoe T
    Int J Hematol; 2012 Aug; 96(2):186-93. PubMed ID: 22791510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic landscape in acute myeloid leukemia and its implications in risk classification and targeted therapies.
    Hou HA; Tien HF
    J Biomed Sci; 2020 Jul; 27(1):81. PubMed ID: 32690020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Relapsed/Refractory Acute Myeloid Leukemia.
    Bose P; Vachhani P; Cortes JE
    Curr Treat Options Oncol; 2017 Mar; 18(3):17. PubMed ID: 28286924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The outcomes of relapsed acute myeloid leukemia in children: Results from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05R study.
    Moritake H; Tanaka S; Miyamura T; Nakayama H; Shiba N; Shimada A; Terui K; Yuza Y; Koh K; Goto H; Kakuda H; Saito A; Hasegawa D; Iwamoto S; Taga T; Adachi S; Tomizawa D
    Pediatr Blood Cancer; 2021 Jan; 68(1):e28736. PubMed ID: 32991072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute myeloid leukemia transformed to a targetable disease.
    Saleh K; Khalifeh-Saleh N; Kourie HR
    Future Oncol; 2020 May; 16(14):961-972. PubMed ID: 32297538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent developments in the treatment of older individuals with acute myeloid leukemia: 2014.
    Michaelis LC; Erba HP
    Curr Opin Hematol; 2015 Mar; 22(2):108-15. PubMed ID: 25603478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing trends in the therapy of acute myeloid leukemia.
    Rowe JM
    Best Pract Res Clin Haematol; 2021 Dec; 34(4):101333. PubMed ID: 34865705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future prospects of therapeutic clinical trials in acute myeloid leukemia.
    Khan M; Mansoor AE; Kadia TM
    Future Oncol; 2017 Mar; 13(6):523-535. PubMed ID: 27771959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis and Therapy of Acute Myeloid Leukemia].
    Medinger M; Heim D; Halter JP; Lengerke C; Passweg JR
    Ther Umsch; 2019; 76(9):481-486. PubMed ID: 32157963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unmet clinical needs and economic burden of disease in the treatment landscape of acute myeloid leukemia.
    Wiese M; Daver N
    Am J Manag Care; 2018 Aug; 24(16 Suppl):S347-S355. PubMed ID: 30132678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single-center, retrospective study of management and outcome of 45 elderly AML patients, diagnosed in 2001.
    Alymara V; Tzouvara E; Vartholomatos G; Chaidos A; Tsiara S; Bourantas KL
    J Exp Clin Cancer Res; 2004 Sep; 23(3):447-54. PubMed ID: 15595635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in treatment of de-novo pediatric acute myeloid leukemia.
    Ribeiro RC
    Curr Opin Oncol; 2014 Nov; 26(6):656-62. PubMed ID: 25226383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel.
    Creutzig U; van den Heuvel-Eibrink MM; Gibson B; Dworzak MN; Adachi S; de Bont E; Harbott J; Hasle H; Johnston D; Kinoshita A; Lehrnbecher T; Leverger G; Mejstrikova E; Meshinchi S; Pession A; Raimondi SC; Sung L; Stary J; Zwaan CM; Kaspers GJ; Reinhardt D;
    Blood; 2012 Oct; 120(16):3187-205. PubMed ID: 22879540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New and emerging therapies for acute myeloid leukaemia.
    Davis JR; Benjamin DJ; Jonas BA
    J Investig Med; 2018 Dec; 66(8):1088-1095. PubMed ID: 30127098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A User's Guide to Novel Therapies for Acute Myeloid Leukemia.
    Patel SA; Gerber JM
    Clin Lymphoma Myeloma Leuk; 2020 May; 20(5):277-288. PubMed ID: 32113891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.